SB
TMO icon

Strategic Blueprint’s Thermo Fisher Scientific TMO Stock Holding History

Strategic Blueprint’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,702
Closed -$825K – 775
2025
Q3 		$825K Buy
1,702
+59
+4% +$27.5K 0.04% 370
2025
Q2 		$666K Buy
1,643
+202
+14% +$84.5K 0.03% 377
2025
Q1 		$717K Buy
1,441
+73
+5% +$39.5K 0.04% 352
2024
Q4 		$712K Buy
1,368
+92
+7% +$50.6K 0.04% 328
2024
Q3 		$789K Buy
1,276
+12
+0.9% +$7.1K 0.05% 300
2024
Q2 		$699K Buy
1,264
+33
+3% +$18.9K 0.05% 303
2024
Q1 		$715K Buy
1,231
+96
+8% +$53.9K 0.05% 308
2023
Q4 		$602K Buy
1,135
+11
+1% +$5.32K 0.05% 324
2023
Q3 		$569K Buy
1,124
+81
+8% +$43.2K 0.05% 313
2023
Q2 		$544K Buy
1,043
+180
+21% +$97.1K 0.05% 307
2023
Q1 		$497K Buy
863
+5
+0.6% +$2.82K 0.05% 310
2022
Q4 		$472K Buy
858
+8
+0.9% +$4.24K 0.05% 308
2022
Q3 		$431K Buy
850
+11
+1% +$6.16K 0.05% 305
2022
Q2 		$456K Buy
839
+284
+51% +$156K 0.06% 294
2022
Q1 		$328K Buy
555
+50
+10% +$28.7K 0.04% 368
2021
Q4 		$337K Buy
505
+50
+11% +$31.2K 0.04% 352
2021
Q3 		$260K Sell
455
-144
-24% -$79K 0.04% 357
2021
Q2 		$302K Buy
+599
New +$283K 0.05% 301
2019
Q4 		– Sell
-21
Closed -$6K – 386
2019
Q3 		$6K Buy
+21
New +$6.01K ﹤0.01% 350

Other funds holding TMO

JSC
J. Stern & Co London, United Kingdom $1.06B AUM 11.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Strategic Blueprint's TMO Position: Q4 2025 in Review

Strategic Blueprint sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 1,702 shares — an estimated $825K sold.

Strategic Blueprint first reported a position in TMO in Q3 2019 and held it in 19 quarters. The position peaked at $825K in Q3 2025. 2,701 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Strategic Blueprint reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • Strategic Blueprint sold 1,702 Thermo Fisher Scientific shares in Q4 2025, an estimated $825K.
  • Strategic Blueprint first reported a position in Thermo Fisher Scientific in Q3 2019 and held it in 19 quarters.
  • Strategic Blueprint's Thermo Fisher Scientific position peaked at $825K in Q3 2025.
  • 2,701 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Strategic Blueprint's 13F filing for Q4 2025, filed 30 Jan 2026.